ESSA Pharma (EPIX) Stock Statistics & Valuation Metrics

ESSA Pharma has a market cap or net worth of ―. The enterprise value is ―.

ESSA Pharma has ― shares outstanding. The number of shares has decreased by -2.65% in one year.

ESSA Pharma’s return on equity (ROE) is -0.22 and return on invested capital (ROIC) is -27.55%.

The current PE Ratio of ESSA Pharma is ―. ESSA Pharma’s PEG ratio is ―.

In the last 12 months, ESSA Pharma had revenue of 0.00 and earned -28.54M in profits. Earnings per share was -0.64.

In the last 12 months, operating cash flow was -20.88M and capital expenditures 0.00, giving a free cash flow of -20.88M billion.

ESSA Pharma pays an annual dividend of ―, resulting in a dividend yield of ―

ESSA Pharma upcoming earnings date is Dec 23, 2025, TBA (Confirmed).

ESSA Pharma as a current ratio of 38.64, with Debt / Equity ratio of 0.25%

In the past 12 months, ESSA Pharma has paid 0.00 in taxes.

ESSA Pharma EV to EBITDA ratio is -5.80, with an EV/FCF ratio of -7.26.

ESSA Pharma has $109.62M in cash and marketable securities with ― in debt, giving a net cash position of $109.62M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for ESSA Pharma is ―, which is 11.43% higher than the current price. The consensus rating is ―